未登录

P

Paola Conti

university of milan

H指数:30

被引数:3,063

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models

第一类PFKFB3共价抑制剂的发现与表征：在PDAC模型中的研究

Journal of Medicinal Chemistry

IF6.8

2026-05-250

OAAI

Targeting ALDH7A1 with covalent inhibitors reveals new chemical space for prostate cancer therapy

靶向ALDH7A1的共价抑制剂揭示了前列腺癌治疗的新化学空间

Journal of Enzyme Inhibition and Medicinal Chemistry

IF5.4

2026-05-110

OA

Target Fidelity and Failure: Structure–Activity Relationship of High-Molecular-Mass Penicillin-Binding Proteins (HMM-PBPs) in Refractory Granulicatella adiacens Endocarditis

IF0

2026-02-050

OA

From Pan-Active to Parasite-Selective Antiparasitic Agents: A Scaffold Hopping Approach

从泛活性到寄生虫选择性抗寄生虫剂：一种骨架跳跃方法

European Journal of Medicinal Chemistry

IF5.9

2025-08-290

OAAI

Two-Step Flow Amidation of Natural Phenolic Acids as Antiradical and Antimicrobial Agents

JOURNAL OF NATURAL PRODUCTS

IF3.6

2025-03-010

PRE

Evaluation of ampicillin plus ceftobiprole combination therapy in treating Enterococcus faecalis infective endocarditis and bloodstream infection

SCIENTIFIC REPORTS

IF3.9

2025-01-280

OAAI

Discovery and characterization of a new class of NAD plus -independent SIRT1 activators

PHARMACOLOGICAL RESEARCH

IF10.5

2024-08-010

OAAI

Chemo-enzymatic flow synthesis of nature-inspired phenolic carbonates and carbamates as antiradical and antimicrobial agents

SUSTAINABLE CHEMISTRY AND PHARMACY

IF5.8

2024-06-012

OAAI

Discovery of 1,3,4-Oxadiazole Derivatives as Broad-Spectrum Antiparasitic Agents

1,3，4-恶二唑衍生物作为广谱抗寄生虫药的发现

ACS INFECTIOUS DISEASES

IF3.8

2024-05-081

OA

An Aminoglycoside-Sparing Regimen with Double Beta-Lactam to Successfully Treat Granulicatella adiacens Prosthetic Aortic Valve Endocarditis-Time to Change Paradigm?

INFECTIOUS DISEASE REPORTS

IF2.4

2024-03-141

OAAI

Effect of glycosylation on the affinity of the MTB protein Ag85B for specific antibodies: towards the design of a dual-acting vaccine against tuberculosis

糖基化对MTB蛋白Ag85B对特异性抗体的亲和力的影响: 针对结核病的双重作用疫苗的设计

IF4.9

2024-01-252

OAAI

Unveiling the Relationship between Ceftobiprole and High-Molecular-Mass (HMM) Penicillin-Binding Proteins (PBPs) in Enterococcus faecalis

ANTIBIOTICS-BASEL

IF4.6

2024-01-091

OA

Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-06-018

OAAI

Role of Stereochemistry on the Biological Activity of Nature-Inspired 3-Br-Acivicin Isomers and Derivatives

IF4.6

2023-04-037

OAAI

Enzymatic continuous-flow preparation of nature-inspired phenolic esters as antiradical and antimicrobial agents

IF9.8

2022-10-013

OA

Continuous-flow stereoselective reduction of prochiral ketones in a whole cell bioreactor with natural deep eutectic solvents

GREEN CHEMISTRY

IF9.2

2022-01-0110

OA

Development of Potent 3-Br-isoxazoline-Based Antimalarial and Antileishmanial Compounds

ACS MEDICINAL CHEMISTRY LETTERS

IF4

2021-10-1311

OA

Covalent inhibitors of GAPDH: From unspecific warheads to selective compounds

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2020-12-0117

OAAI

Immobilized enzyme reactors based on nucleoside phosphorylases and 2?- deoxyribosyltransferase for the in -flow synthesis of pharmaceutically relevant nucleoside analogues

BIORESOURCE TECHNOLOGY

IF9

2020-07-0130

OAAI

An Enzymatic Flow-Based Preparative Route to Vidarabine

IF4.6

2020-03-0915

OAAI